Literature DB >> 10194161

Diurnal variation in lung function in subgroups from two Dutch populations: consequences for longitudinal analysis.

G J Borsboom1, W van Pelt, H C van Houwelingen, B G van Vianen, J P Schouten, P H Quanjer.   

Abstract

We studied circadian variation in FVC, FEV1, PEF, TLC, VC, and RV between 9:00 A.M. and 9:00 P.M. and analyzed how this variation affected estimated longitudinal change. Data from 876 adults were obtained in a longitudinal survey of samples from two Dutch areas. Subjects participated in four surveys held at 3-yr intervals between 1975 and 1985. FVC, FEV1, PEF, and VC increased from 9:00 A.M. until noon and decreased afterwards. TLC was constant over the day, whereas RV decreased from 9:00 A.M. to noon. Average variation in FVC, FEV1 and PEF, expressed as percentages of average level, was 4. 8% (200 ml), 2.8% (86 ml), and 3.1% (250 ml/s), respectively. These results are compatible with circadian changes in airway size. No differences in variability were found between men and women. Significantly larger changes between 9:00 A.M. and noon were found in young adults, smokers, and those with respiratory symptoms than in other subgroups. Adjustment for diurnal variation reduced, albeit slightly, residual standard deviations of estimated longitudinal declines. Average diurnal change was large relative to underlying longitudinal change. Its effect on longitudinal change within an individual can therefore be large depending on age, smoking habits, symptomatology, number of visits, time of measurement, and difference in time between measurements. However, when people are measured at random times during the day for at least three visits, or when measurements are made after 11:00 A.M., effects of diurnal variation in pulmonary function on estimated average longitudinal decline are minimal.

Entities:  

Mesh:

Year:  1999        PMID: 10194161     DOI: 10.1164/ajrccm.159.4.9703106

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  30 in total

Review 1.  Circadian molecular clock in lung pathophysiology.

Authors:  Isaac K Sundar; Hongwei Yao; Michael T Sellix; Irfan Rahman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-09-11       Impact factor: 5.464

2.  Are women more sensitive than men to 2-propanol and m-xylene vapours?

Authors:  L Ernstgård; E Gullstrand; A Löf; G Johanson
Journal:  Occup Environ Med       Date:  2002-11       Impact factor: 4.402

3.  Disruption of Sirtuin 1-Mediated Control of Circadian Molecular Clock and Inflammation in Chronic Obstructive Pulmonary Disease.

Authors:  Hongwei Yao; Isaac K Sundar; Yadi Huang; Janice Gerloff; Michael T Sellix; Patricia J Sime; Irfan Rahman
Journal:  Am J Respir Cell Mol Biol       Date:  2015-12       Impact factor: 6.914

4.  A variability study of regional alveolar oxygen tension measurement in humans using hyperpolarized (3) He MRI.

Authors:  Hooman Hamedani; Stephen J Kadlecek; Masaru Ishii; Kiarash Emami; Nicholas N Kuzma; Yi Xin; Milton Rossman; Rahim R Rizi
Journal:  Magn Reson Med       Date:  2013-02-04       Impact factor: 4.668

5.  Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease.

Authors:  P M A Calverley; A Lee; L Towse; J van Noord; T J Witek; S Kelsen
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

6.  Underdiagnosed asthma in South Australia.

Authors:  R J Adams; D H Wilson; S Appleton; A Taylor; E Dal Grande; C R Chittleborough; R E Ruffin
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

7.  Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD).

Authors:  T R Schermer; J E Jacobs; N H Chavannes; J Hartman; H T Folgering; B J Bottema; C van Weel
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

8.  Cement dust exposure and acute lung function: a cross shift study.

Authors:  Zeyede K Zeleke; Bente E Moen; Magne Bråtveit
Journal:  BMC Pulm Med       Date:  2010-04-14       Impact factor: 3.317

9.  Longitudinal FEV1 dose-response model for inhaled PF-00610355 and salmeterol in patients with chronic obstructive pulmonary disease.

Authors:  Jace C Nielsen; Matthew M Hutmacher; Adriaan Cleton; Steven W Martin; Jakob Ribbing
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-09-23       Impact factor: 2.745

10.  Short term exposure to cooking fumes and pulmonary function.

Authors:  Sindre Svedahl; Kristin Svendsen; Torgunn Qvenild; Ann Kristin Sjaastad; Bjørn Hilt
Journal:  J Occup Med Toxicol       Date:  2009-05-04       Impact factor: 2.646

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.